{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:15:37Z","timestamp":1789722937527,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1038\/ki.2014.376","type":"journal-article","created":{"date-parts":[[2014,12,10]],"date-time":"2014-12-10T16:36:46Z","timestamp":1418229406000},"page":"1055-1060","source":"Crossref","is-referenced-by-count":73,"title":["Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease"],"prefix":"10.1016","volume":"87","author":[{"given":"Elaine","family":"Ku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David V.","family":"Glidden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten L.","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sarnak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hocine","family":"Tighiouart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-yuan","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2014.376_bb0010","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/j.1523-1755.2004.00894.x","article-title":"The burden of kidney disease: improving global outcomes","volume":"66","author":"Eknoyan","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.376_bb0015","year":"2013"},{"key":"10.1038\/ki.2014.376_bb0020","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2014.376_bb0025","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMoa021583","article-title":"Effect of dialysis dose and membrane flux in maintenance hemodialysis","volume":"347","author":"Eknoyan","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2014.376_bb0030","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1681\/ASN.V1351307","article-title":"Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial","volume":"13","author":"Paniagua","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.376_bb0035","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Chertow","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2014.376_bb0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ki.1995.22","article-title":"Clinical and echocardiographic disease in patients starting end-stage renal disease therapy","volume":"47","author":"Foley","year":"1995","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.376_bb0045","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group","volume":"330","author":"Klahr","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2014.376_bb0050","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1053\/j.ajkd.2007.03.017","article-title":"Early, intermediate, and long-term risk factors for mortality in incident dialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study","volume":"49","author":"Plantinga","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.376_bb0055","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1523-1755.2004.00385.x","article-title":"Body mass index, dialysis modality, and survival: analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study","volume":"65","author":"Abbott","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.376_bb0060","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/archinternmed.2012.3020","article-title":"Frailty, dialysis initiation, and mortality in end-stage renal disease","volume":"172","author":"Bao","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1038\/ki.2014.376_bb0065","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"10.1038\/ki.2014.376_bb0070","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","article-title":"Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial","volume":"365","author":"Ruggenenti","year":"2005","journal-title":"Lancet"},{"key":"10.1038\/ki.2014.376_bb0075","doi-asserted-by":"crossref","first-page":"342","DOI":"10.7326\/0003-4819-142-5-200503010-00009","article-title":"The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study","volume":"142","author":"Sarnak","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.2014.376_bb0080","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"10.1038\/ki.2014.376_bb0085","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1001\/jama.1990.03440130083030","article-title":"Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypotheses of the trial. The Multiple Risk Factor Intervention Trial Research Group","volume":"263","year":"1990","journal-title":"JAMA"},{"key":"10.1038\/ki.2014.376_bb0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2337\/dc13-2116","article-title":"Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study","volume":"37","author":"Lachin","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1038\/ki.2014.376_bb0095","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1001\/jama.290.16.2159","article-title":"Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study","volume":"290","author":"Writing Team for the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group","year":"2003","journal-title":"JAMA"},{"key":"10.1038\/ki.2014.376_bb0100","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1056\/NEJMoa1111732","article-title":"Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes","volume":"365","author":"DCCT\/EDIC Research Group","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2014.376_bb0105","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2014.376_bb0110","first-page":"68","article-title":"How good are the data? USRDS data validation special study","volume":"20","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.376_bb0115","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.V113520","article-title":"Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD","volume":"11","author":"Longenecker","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.376_bb0120","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/aje\/kwp155","article-title":"Identifying a national death index match","volume":"170","author":"Fillenbaum","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1038\/ki.2014.376_bb0125","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1001\/jama.2013.4208","article-title":"Mortality risk among children initially treated with dialysis for end-stage kidney disease, 1990-2010","volume":"309","author":"Mitsnefes","year":"2013","journal-title":"JAMA"},{"key":"10.1038\/ki.2014.376_bb0130","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.2010.924","article-title":"Regional variation in health care intensity and treatment practices for end-stage renal disease in older adults","volume":"304","author":"O'Hare","year":"2010","journal-title":"JAMA"},{"key":"10.1038\/ki.2014.376_bb0135","doi-asserted-by":"crossref","first-page":"754","DOI":"10.7326\/0003-4819-123-10-199511150-00003","article-title":"Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study","volume":"123","author":"Peterson","year":"1995","journal-title":"Ann Intern Med"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815300958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815300958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T04:58:30Z","timestamp":1650776310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815300958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0085253815300958"],"URL":"https:\/\/doi.org\/10.1038\/ki.2014.376","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}